# Theraptosis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/theraptosis

- Industry: Pharmaceuticals
- Headquarters: Romainville, France
- Total disclosed funding: $12M
- Latest round: Series D (Jan 25, 2007)
- Investors on record: 6

## About

Theraptosis is a biopharmaceutical company engages in the designing and development of drugs for cancer and neurodegenerative diseases.

## Funding rounds

- Series D, Jan 25, 2007, $9.2M — 123 Investment Managers, Auriga Partners, Andera Partners, Seventure Partners, CDC Entreprises, Blue Medical Investments
- Series B, Nov 18, 2002, $2.6M — Andera Partners, Seventure Partners, CDC Entreprises

## Investors

- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series B, Series D
- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series B, Series D
- CDC Entreprises — Series B, Series D
- 123 Investment Managers (https://capitalatlas.ai/funds/123-investment-managers) — Series D
- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series D
- Blue Medical Investments — Series D